United States: CMS Innovation Center Announces Sickle Cell Disease Focus Under Cell And Gene Therapy Access Model - Crowell & Moring LLP

United States: CMS Innovation Center Announces Sickle Cell Disease Focus Under Cell And Gene Therapy Access Model - Crowell & Moring LLP

Mondaq

Published

On January 30, the Centers for Medicare & Medicaid Services' (CMS') Innovation Center announced that sickle cell disease (SCD) will be the first focus of the Cell and Gene Therapy (CGT)...

Full Article